Imbed Biosciences Chases Nasal Spray to Combat Covid-19 Spread

DECEMBER 3, 2020

Imbed Biosciences has been featured on Bloomberg.com for its efforts to combat Covid-19 spread. Read the article here Imbed Biosciences Chases Nasal Spray to Combat Covid-19 Spread

About Imbed Biosciences, Inc.

Imbed is a privately held biotech company registered with FDA as a medical device manufacturer with an ISO 13485 certified quality management system. The company has a portfolio of products in development based on its patented Microlyte® Matrix technology for tissue engineering to combat local pain and infections in complex wounds such as burns, chronic ulcers, surgical wounds, epidermolysis bullosa, and colorectal surgeries. The research is funded in part by a Small Business Innovation Research grant #5R44AR061913 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. For more information, please visit www.imbedbio.com and www.MicrolyteMatrix.com.